Updated:
MacNeil Capital Management
Robert MacNeil's Chicago permanent-capital vehicle has bought pharmaceutical royalties and tax-lien real estate since 1979.
MacNeil Capital Management
Robert MacNeil founded MacNeil Capital Management in Chicago in 1979, deploying personal and partnered capital into deeply out-of-favor public equities. The firm's origins trace to MacNeil's early-career observation that small, post-reorganization micro-cap companies frequently trade at steep discounts to their net current asset value — a variant of the Benjamin Graham 'net-net' framework that he has applied across multiple market cycles. Unlike most value managers who build diversified portfolios, MacNeil concentrates assets into a small number of positions where he believes liquidation value exceeds the purchase price by a wide margin. The firm's strategy blends equity and real asset ownership through a buy-and-hold approach. Public records identify holdings across several distinct categories: pharmaceutical royalty trusts — securities that entitle holders to a share of drug revenue streams — and real estate acquired through tax-lien foreclosures and bankruptcy auctions. The portfolio includes North Carolina timber tracts picked up through county tax sales and a Delaware-incorporated pharmaceutical royalty entity. These instruments rarely appear in standard institutional portfolios. Sourcing relies on monitoring court dockets, SEC deregistration filings, and corporate trust liquidations rather than broker-dealer research or management meetings. MacNeil Capital Management operates without a separate marketing team, external website detailing current performance, or filings that indicate outside institutional limited partners. The firm does not report 13F filings, suggesting it keeps equity positions below the SEC reporting threshold or holds securities outside standard registration. Philanthropic or family structures beyond the core investment entity remain undocumented in available records. The firm's permanent-capital structure eliminates duration mismatches and redemption pressures, allowing MacNeil to wait years for post-bankruptcy restructurings or tax-lien redemption periods to play out. This contrasts with the quarterly liquidity requirements that constrain most value-oriented funds and represents the firm's primary architectural distinction.
General information
Firm type
Asset Manager
Year founded
1979
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Chicago
Corporate office
Chicago, IL, United States
Principals
Robert MacNeil
Founder and President
Sector focus
Frequently asked questions
Who runs investment decisions at MacNeil Capital Management?
Founder and President Robert MacNeil directs all investment decisions. He established the firm in 1979 and remains the sole named principal in public filings and corporate records.
What asset classes does MacNeil Capital Management invest in?
The firm concentrates on deeply discounted micro-cap equities, pharmaceutical royalty trusts, and real estate acquired through tax-lien foreclosures and bankruptcy auctions. Public records identify timber holdings in North Carolina and a Delaware-incorporated pharma royalty entity, reflecting an approach that rarely overlaps with institutional benchmarks.
Does MacNeil Capital Management operate like a typical hedge fund?
No. It functions as a permanent-capital holding company rather than a fund with quarterly redemptions. MacNeil does not appear to file 13F ownership reports or maintain a standard investor relations function, suggesting a proprietary or closely held capital base rather than a pooled third-party fund structure.
How does the firm source its investment ideas?
Sourcing relies on monitoring bankruptcy court dockets, SEC deregistration filings, corporate trust liquidations, and county tax-lien sale notices — channels that fall outside the broker-dealer research most funds depend on. Positions often involve securities that have been orphaned by forced index deletions or institutional mandate screens.
What investment approach distinguishes MacNeil's strategy from other value investors?
MacNeil applies a liquidation-value discipline to illiquid claim types — pharmaceutical royalty rights and tax-repossessed land — rather than standard operating companies. The permanent-capital structure removes the pressure to liquidate positions before post-reorganization catalysts materialize, a constraint that historically limits distressed-value strategies within drawdown fund formats.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: